U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CVM GFI #201 SECG for The Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
  1. Search for FDA Guidance Documents

SMALL ENTITY COMPLIANCE GUIDE

CVM GFI #201 SECG for The Index of Legally Marketed Unapproved New Animal Drugs for Minor Species July 2014

Download the Final Small Entity Compliance Guide
Final
Docket Number:
FDA-2010-D-0435
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine

On December 6, 2007 (72 FR 69108), FDA published a final rule in the Federal Register, entitled “Index of Legally Marketed Unapproved New Animal Drugs for Minor Species.” This final rule implements section 572 of the Federal Food, Drug, and Cosmetic Act (FFDCA), which provides for a public index listing of legally marketed unapproved new animal drugs for minor species of animals (species other than cattle, horses, swine, chickens, turkeys, dogs, and cats). Within limitations established by the statute, such indexing provides a basis for legally marketing an unapproved new animal drug intended for use in a minor species.

FDA has prepared this Small Entities Compliance Guide in accordance with section 212 of the Small Business Regulatory Enforcement Fairness Act of 1996 (Public Law 104-121). This document is intended to provide guidance on the requirements of Title 21, Code of Federal Regulations, new Part 516, subpart C.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2010-D-0435.

Questions?

Back to Top